Pain Therapeutics (PTIE) Tops Q3 EPS by 1c

Pain Therapeutics (NASDAQ: PTIE) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09).

At September 30, 2016, cash and investments were $21.8 million, compared to $24.6 million at June 30, 2016. The Company has no debt.

For earnings history and earnings-related data on Pain Therapeutics (PTIE) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c